// App-Quantinova.ai

POS-908 : COULD DEXAMETHASONE ADMINISTRATION BE LIFESAVING IN PATIENTS ON IMMUNOSUPPRESSION INFECTED BY COVID 19?

Researchers

Presenter

  • A.F. MEGAHED

Principal Investigators

  • D. Abouelkheir Abdalla Mohamed

  • O. Ahmad Al Nafel

  • N. Sayed-Ahmed

Medical Centers

  • Mansoura University, Nephrology and Dialysis Unit MNDU, Mansoura, Egypt

  • King Salman Specialized Hospital in Hail- Saudi Arabia, Intensive Care Unit, Hail, Saudi Arabia

Locations

  • Egypt

  • Saudi Arabia

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Infectious Diseases (ID)

  • Autoimmune (AI)

Disease

  • Renal insufficiency

  • Lupus nephritis

  • Nephritis

  • Pneumonia

  • Coronavirus disease

  • Lupus

Biomarkers

  • N/A

Drug/Treatment

  • Heparin

  • Mycophenolate mofetil

  • CKD-4101

  • Hydroxychloroquine

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Mycophenolic acid

  • Oraprine

  • Prednisolone

  • Favipiravir

  • Enoxaparin

  • Enoxaparin sodium

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved